...
首页> 外文期刊>The Journal of Nutrition: Official Organ of the American Institute of Nutrition >The Role of Probiotic Cultures in the Control of Gastrointestinal Health
【24h】

The Role of Probiotic Cultures in the Control of Gastrointestinal Health

机译:益生菌培养物在控制胃肠道健康中的作用

获取原文

摘要

The use of probiotics to enhance intestinal health has been proposed for many years. Probiotics are traditionally defined as viable microorganisms that have a beneficial effect in the prevention and treatment of specific pathologic conditions when they are ingested. There is a relatively large volume of literature that supports the use of probiotics to prevent or treat intestinal disorders. However, the scientific basis of probiotic use has been firmly established only recently, and sound clinical studies have begun to be published. Currently, the best-studied probiotics are the lactic acid bacteria, particularly Lactobacillus sp. and Bifidobacterium sp. However, other organisms used as probiotics in humans include Escherichia coli, Streptococcus sp., Enterococcus sp., Bacteroides sp., Bacillus sp., Propionibacterium sp. and various fungi. Some probiotic preparations contain mixtures of more than one bacterial strain. Probiotics have been examined for their effectiveness in the prevention and treatment of a diverse spectrum of gastrointestinal disorders such as antibiotic-associated diarrhea (including Clostridium difficile–associated intestinal disease), infectious bacterial and viral diarrhea (including diarrhea caused by rotavirus, Shigella, Salmonella, enterotoxigenic E. coli, Vibrio cholerae and human immunodeficiency virus/acquired immunodeficiency disorder, enteral feeding diarrhea, Helicobacter pylori gastroenteritis, sucrase maltase deficiency, inflammatory bowel disease, irritable bowel syndrome, small bowel bacterial overgrowth and lactose intolerance. Probiotics have been found to inhibit intestinal bacterial enzymes involved in the synthesis of colonic carcinogens. There are many mechanisms by which probiotics enhance intestinal health, including stimulation of immunity, competition for limited nutrients, inhibition of epithelial and mucosal adherence, inhibition of epithelial invasion and production of antimicrobial substances. Probiotics represent an exciting prophylactic and therapeutic advance, although additional investigations must be undertaken before their role in intestinal health can be delineated clearly.
机译:多年来已经提出使用益生菌来增强肠道健康。益生菌传统上被定义为可生存的微生物,这些微生物在摄入后对预防和治疗特定的病理状况具有有益的作用。有大量文献支持使用益生菌预防或治疗肠道疾病。然而,益生菌使用的科学基础直到最近才被牢固确立,并且健全的临床研究已经开始发表。目前,研究最好的益生菌是乳酸菌,尤其是乳酸杆菌。和双歧杆菌但是,在人中用作益生菌的其他生物包括大肠杆菌,链球菌属,肠球菌属,拟杆菌属,芽孢杆菌属,丙酸杆菌属。和各种真菌。一些益生菌制剂包含一种以上细菌菌株的混合物。已对益生菌在预防和治疗各种胃肠道疾病(例如与抗生素相关的腹泻(包括艰难梭菌相关的肠道疾病),传染性细菌和病毒性腹泻(包括由轮状病毒,志贺氏菌,沙门氏菌引起的腹泻)中的有效性进行了检查,产肠毒素的大肠杆菌,霍乱弧菌和人类免疫缺陷病毒/后天免疫缺陷疾病,肠内喂养腹泻,幽门螺杆菌胃肠炎,蔗糖酶,麦芽糖酶缺乏症,炎症性肠病,肠易激综合症,小肠细菌过度生长和乳糖不耐症。抑制结肠癌致癌物质合成过程中的肠道细菌酶益生菌可通过多种机制增强肠道健康,包括刺激免疫力,竞争有限的营养素,抑制上皮和粘膜粘附,抑制上皮侵袭。和生产抗菌物质。益生菌代表了令人兴奋的预防和治疗进展,尽管在明确其在肠道健康中的作用之前还必须进行其他研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号